Your session is about to expire
← Back to Search
Behavioural Intervention
Neurofeedback for Adolescent Depression
N/A
Recruiting
Led By Mary Woody, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants will include 90 female adolescents ages 13 years 0 months through 15 years 11 months at study entry.
Be younger than 18 years old
Must not have
Being pre-pubertal
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and following laboratory stressor (~30 minutes)
Awards & highlights
Summary
This trial is testing if a new method can be used to help predict and treat depression in adolescents, specifically by looking at how they react to positive and negative stimuli.
Who is the study for?
This trial is for female adolescents aged 13 to nearly 16 who may be at risk for depression. They must have normal intelligence, no history of neurological issues or serious medical conditions, and cannot have taken antidepressants or have a history of certain mental health disorders.
What is being tested?
The study tests if a new method using EEG can predict depression in teens and if neurofeedback can change how they pay attention to emotions, possibly preventing mood problems later on.
What are the potential side effects?
Neurofeedback is generally considered safe but might cause temporary discomfort like headaches or fatigue. Since it's non-invasive, there are minimal risks associated with the procedure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a girl aged 13 to 15 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have not started puberty.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and following laboratory stressor (~30 minutes)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and following laboratory stressor (~30 minutes)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from baseline in affect-biased attention subsequently following neurofeedback (~1 hour)
Secondary study objectives
Change from baseline in anxiety after laboratory stressor, which follows neurofeedback
Change from baseline in sadness after laboratory stressor, which follows neurofeedback
Trial Design
1Treatment groups
Experimental Treatment
Group I: NeurofeedbackExperimental Treatment1 Intervention
Participants will receive feedback about their attention to negative distractors during each trial using activity from their brain waves, which will help them reduce their attention to distractors.
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,762 Previous Clinical Trials
16,347,933 Total Patients Enrolled
121 Trials studying Depression
33,885 Patients Enrolled for Depression
National Institute of Mental Health (NIMH)NIH
2,869 Previous Clinical Trials
2,777,466 Total Patients Enrolled
687 Trials studying Depression
258,215 Patients Enrolled for Depression
Mary Woody, PhD2.77 ReviewsPrincipal Investigator - University of Pittsburgh
University of Pittsburgh
1Patient Review
I didn't enjoy my interactions with her. She was rude and didn't listen to my answers. She was also awkward with the young patients.
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have not started puberty.You have ever been diagnosed with a depressive disorder according to the DSM 5.You have been diagnosed with a serious mental health condition like schizophrenia, bipolar disorder, or autism spectrum disorder.I am a girl aged 13 to 15 years old.Your vision problems cannot be fixed with glasses or surgery.You have a high risk of hurting yourself or others, or have recent thoughts of suicide.You have had a serious head injury in the past or were born with a neurological condition.I have taken antidepressants in the past.You have a history of a serious medical or neurological condition at any point in your life.
Research Study Groups:
This trial has the following groups:- Group 1: Neurofeedback
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger